Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with Low-Volume de Novo Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - December 5, 2024 716 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-1 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Benefit Assessment of Adding Irinotecan to Capecitabine-Based Neoadjuvant Chemoradiation for Locally... November 3, 2020 Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer December 1, 2023 Trastuzumab Deruxtecan Leads to Longer PFS and OS Compared with Chemotherapy... July 14, 2022 Reflections on My First Year as NCI Director November 1, 2018 Load more HOT NEWS Young Man’s “Water You Can Eat” Invention for His Grandma with... ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of... With Longer Follow-Up, Trastuzumab Deruxtecan Continues to Demonstrate Superior Efficacy Over... Ending smoking could more than halve England’s cancer inequality gap
